1. Home
  2. BRTX vs CENN Comparison

BRTX vs CENN Comparison

Compare BRTX & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • CENN
  • Stock Information
  • Founded
  • BRTX 1997
  • CENN 2013
  • Country
  • BRTX United States
  • CENN United States
  • Employees
  • BRTX N/A
  • CENN N/A
  • Industry
  • BRTX Managed Health Care
  • CENN Auto Manufacturing
  • Sector
  • BRTX Health Care
  • CENN Consumer Discretionary
  • Exchange
  • BRTX Nasdaq
  • CENN Nasdaq
  • Market Cap
  • BRTX 12.8M
  • CENN 13.8M
  • IPO Year
  • BRTX N/A
  • CENN N/A
  • Fundamental
  • Price
  • BRTX $1.54
  • CENN $0.21
  • Analyst Decision
  • BRTX
  • CENN
  • Analyst Count
  • BRTX 0
  • CENN 0
  • Target Price
  • BRTX N/A
  • CENN N/A
  • AVG Volume (30 Days)
  • BRTX 331.3K
  • CENN 21.4M
  • Earning Date
  • BRTX 11-13-2025
  • CENN 11-12-2025
  • Dividend Yield
  • BRTX N/A
  • CENN N/A
  • EPS Growth
  • BRTX N/A
  • CENN N/A
  • EPS
  • BRTX N/A
  • CENN N/A
  • Revenue
  • BRTX $605,200.00
  • CENN $30,189,622.00
  • Revenue This Year
  • BRTX $232.67
  • CENN N/A
  • Revenue Next Year
  • BRTX $52.92
  • CENN N/A
  • P/E Ratio
  • BRTX N/A
  • CENN N/A
  • Revenue Growth
  • BRTX 247.62
  • CENN 143.95
  • 52 Week Low
  • BRTX $1.19
  • CENN $0.19
  • 52 Week High
  • BRTX $2.55
  • CENN $1.47
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 47.02
  • CENN 26.67
  • Support Level
  • BRTX $1.49
  • CENN $0.21
  • Resistance Level
  • BRTX $1.70
  • CENN $0.24
  • Average True Range (ATR)
  • BRTX 0.09
  • CENN 0.04
  • MACD
  • BRTX -0.01
  • CENN 0.01
  • Stochastic Oscillator
  • BRTX 33.33
  • CENN 7.63

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

Share on Social Networks: